The First Affiliated Hospital with Nanjing Medical University: Lymphoma, B-Cell trials

The registry lists 14 Lymphoma, B-Cell studies with The First Affiliated Hospital with Nanjing Medical University as lead sponsor. 3 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 4Phase 2 5Phase 3 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell LymphomasNot yet recruitingNCT07563543Early Phase 1
• Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular SubtypesRecruitingNCT06891157Phase 2
• A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCLNot yet recruitingNCT06516978Phase 2
• On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of LymphomaStatus unknownNCT06503211Phase 1
• Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin LymphomaTerminatedNCT06295549Phase 1
• R-MINE+X in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaStatus unknownNCT05784987Not applicable
• R-CMOP in Patients With Primary Diffuse Large B-cell LymphomaStatus unknownNCT05777369Not applicable
• A Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell LymphomaStatus unknownNCT05200312Phase 2
• Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell LymphomaStatus unknownNCT04432402Not applicable
• CTA101 in the Treatment of Relapsed or Refractory Diffuse Large B-cell LymphomaStatus unknownNCT04026100Phase 1
• Lenalidomide, Rituximab, Gemcitabine, Oxaliplatin and Dexamethasone in Relapse and Refractory DLBCLStatus unknownNCT03795571Phase 1
• XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy SubjectsStatus unknownNCT03598179Phase 2
• Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell LymphomaStatus unknownNCT02767674Phase 3
• Trial of R-GemOx Regimen in Previously Untreated Elderly Patients With DLBCL.Status unknownNCT01670370Phase 2